BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9389704)

  • 1. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
    Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
    Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
    Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
    Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submicroscopic insertion of RARalpha gene into chromosome 15 in two cases of acute promyelocytic leukemia.
    Viguié F; Aboura A; Ramond S; Bouscary D; Baudard M; Chomienne C; Marie JP
    Cancer Genet Cytogenet; 2000 Jun; 119(2):162-4. PubMed ID: 10867154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".
    Grimwade D; Biondi A; Mozziconacci MJ; Hagemeijer A; Berger R; Neat M; Howe K; Dastugue N; Jansen J; Radford-Weiss I; Lo Coco F; Lessard M; Hernandez JM; Delabesse E; Head D; Liso V; Sainty D; Flandrin G; Solomon E; Birg F; Lafage-Pochitaloff M
    Blood; 2000 Aug; 96(4):1297-308. PubMed ID: 10942371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.
    Zhang Z; Xu Y; Jiang M; Kong F; Chen Z; Liu S; Li F
    Cancer Biol Ther; 2020 Apr; 21(4):309-314. PubMed ID: 31959056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
    Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
    Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant complex translocations involving chromosomes 1, 9, 9, 15 and 17 in acute promyelocytic leukemia without RAR alpha/PML gene fusion rearrangement.
    Gogineni SK; Shah HO; Chester M; Lin JH; Garrison M; Alidina A; Bayani E; Verma RS
    Leukemia; 1997 Apr; 11(4):514-8. PubMed ID: 9096691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
    Eclache V; Viguie F; Frocrain C; Cassinat B; Chomienne C; Cymbalista F; Fenaux P
    Cancer Genet Cytogenet; 2005 May; 159(1):69-73. PubMed ID: 15860361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
    Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
    Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of simple variant translocations in acute promyelocytic leukemia.
    Borrow J; Shipley J; Howe K; Kiely F; Goddard A; Sheer D; Srivastava A; Antony AC; Fioretos T; Mitelman F
    Genes Chromosomes Cancer; 1994 Apr; 9(4):234-43. PubMed ID: 7519045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).
    Bennour A; Tabka I; Youssef YB; Zaier M; Hizem S; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):409. PubMed ID: 23292868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
    Schoch C; Schnittger S; Kern W; Lengfelder E; Löffler H; Hiddemann W; Haferlach T
    Hematol J; 2002; 3(5):259-63. PubMed ID: 12391544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PML/RARalpha fusion gene transcripts that showed no t(15;17) with conventional karyotyping and fluorescent in situ hybridization.
    Choughule A; Polampalli S; Amre P; Shinde S; Banavali S; Prabhash K; Nair R; Subramanian PG; Gujral S; Parikh PM
    Genet Mol Res; 2009 Jan; 8(1):1-7. PubMed ID: 19224461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of PML/RARalpha gene rearrangement in suspected acute promyelocytic leukemia patients using dual-color fluorescence in situ hybridization on bone marrow smears].
    Zhu YL; Wu YF; Pan JL; Xue YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):757-60. PubMed ID: 15631655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masked t(15;17) APL with the insertion of PML-RARalpha fusion gene in 4q21.
    Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Itoyama T; Gotoh M; Taniwaki M; Tubouchi H
    Leuk Res; 2009 Nov; 33(11):1552-5. PubMed ID: 19477514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
    Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
    Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.